Novo Nordisk rebrands diabetes tablet as Ozempic in US
Go back to Novo Nordisk rebrands diabetes tablet as Ozempic in US| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1133.00 -27.95 (2.41%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1160.95 | 52 Week High | $88.16 | |||
| Open | $1165.00 | 52 Week Low | $67.88 | |||
| Day High | $1169.99 | P/E | 262.27 | |||
| Day Low | $1132.81 | EPS | $4.32 | |||
| Volume | 2,437,568 | |||||
| NOVO-NORDISK A/S (NYSE: NVO) | Delayed: 43.88 -0.08 (0.18%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $43.96 | 52 Week High | $59.00 | |||
| Open | $43.94 | 52 Week Low | $32.80 | |||
| Day High | $44.60 | P/E | N/A | |||
| Day Low | $43.72 | EPS | $0.00 | |||
| Volume | 14,796,982 | |||||
